Search Results Search Sort by RelevanceMost Recent Health Law Jul 2009 Court Support for FDA Regulation of Drug Importation Kristin E. Schleiter, JD, LLM U.S. regulations prohibit the importation of drugs from foreign countries by individuals and groups other than the manufacturer of the drugs. Virtual Mentor. 2009;11(7):521-526. doi: 10.1001/virtualmentor.2009.11.7.hlaw1-0907. Medicine and Society Nov 2009 Medical Education Meets Health Care Reform Jordan J. Cohen, MD There are four key elements of health system reform that medical educators must endeavor to implement. Virtual Mentor. 2009;11(11):896-899. doi: 10.1001/virtualmentor.2009.11.11.msoc1-0911. Health Law Feb 2004 Disputing Parental Judgment in a Case of Dialysis Douglas Brosnan, JD In cases where a parent is denying life-saving medical treatment, physician paternalism can step in to help provide the proper care to the patient. Virtual Mentor. 2004;6(2):98-101. doi: 10.1001/virtualmentor.2004.6.2.hlaw1-0402. Policy Forum Nov 2004 Genetic Samples and Genetic Philanthropy Michael E. Berens, PhD and Gary E. Marchant, PhD, JD Genetic research is threatened by lack of samples, and public policy should be developed to encourage public participation. Virtual Mentor. 2004;6(11):509-511. doi: 10.1001/virtualmentor.2004.6.11.pfor2-0411. Podcast Jul 2024 Author Interview: “When Are ‘Paraphernalia’ Critical Medical Supplies?” Dr Donald Egan joins Ethics Talk to discuss his article, coauthored with Drs Adriane M. dela Cruz, Sarah E. Baker, and John Z. Sadler: “When Are ‘Paraphernalia’ Critical Medical Supplies?” Health Law Jul 2024 What Should the US Learn From New York’s and Portugal’s Approaches to the Opioid Crisis? Maura McGinnity Some US localities are trying interventions modeled on international approaches to decriminalization. AMA J Ethics. 2024;26(7):E546-550. doi: 10.1001/amajethics.2024.546. Case and Commentary Jul 2024 When Are “Paraphernalia” Critical Medical Supplies? Adriane M. dela Cruz, MD, PhD, Donald Egan, MD, MPH, Sarah E. Baker, MD, MA, and John Z. Sadler, MD Evidence of harm reduction interventions’ morbidity and mortality benefits is abundant and of high quality. AMA J Ethics. 2024;26(7):E527-533. doi: 10.1001/amajethics.2024.527. Pagination First page « First Previous page ‹ Previous … Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Page 12 Page 13 Current page 14
Health Law Jul 2009 Court Support for FDA Regulation of Drug Importation Kristin E. Schleiter, JD, LLM U.S. regulations prohibit the importation of drugs from foreign countries by individuals and groups other than the manufacturer of the drugs. Virtual Mentor. 2009;11(7):521-526. doi: 10.1001/virtualmentor.2009.11.7.hlaw1-0907.
Medicine and Society Nov 2009 Medical Education Meets Health Care Reform Jordan J. Cohen, MD There are four key elements of health system reform that medical educators must endeavor to implement. Virtual Mentor. 2009;11(11):896-899. doi: 10.1001/virtualmentor.2009.11.11.msoc1-0911.
Health Law Feb 2004 Disputing Parental Judgment in a Case of Dialysis Douglas Brosnan, JD In cases where a parent is denying life-saving medical treatment, physician paternalism can step in to help provide the proper care to the patient. Virtual Mentor. 2004;6(2):98-101. doi: 10.1001/virtualmentor.2004.6.2.hlaw1-0402.
Policy Forum Nov 2004 Genetic Samples and Genetic Philanthropy Michael E. Berens, PhD and Gary E. Marchant, PhD, JD Genetic research is threatened by lack of samples, and public policy should be developed to encourage public participation. Virtual Mentor. 2004;6(11):509-511. doi: 10.1001/virtualmentor.2004.6.11.pfor2-0411.
Podcast Jul 2024 Author Interview: “When Are ‘Paraphernalia’ Critical Medical Supplies?” Dr Donald Egan joins Ethics Talk to discuss his article, coauthored with Drs Adriane M. dela Cruz, Sarah E. Baker, and John Z. Sadler: “When Are ‘Paraphernalia’ Critical Medical Supplies?”
Health Law Jul 2024 What Should the US Learn From New York’s and Portugal’s Approaches to the Opioid Crisis? Maura McGinnity Some US localities are trying interventions modeled on international approaches to decriminalization. AMA J Ethics. 2024;26(7):E546-550. doi: 10.1001/amajethics.2024.546.
Case and Commentary Jul 2024 When Are “Paraphernalia” Critical Medical Supplies? Adriane M. dela Cruz, MD, PhD, Donald Egan, MD, MPH, Sarah E. Baker, MD, MA, and John Z. Sadler, MD Evidence of harm reduction interventions’ morbidity and mortality benefits is abundant and of high quality. AMA J Ethics. 2024;26(7):E527-533. doi: 10.1001/amajethics.2024.527.